Enjaymo 55292-0820
Generic: Sutimlimab-Jome
Product NDC
55292-0820- Manufacturer
- Recordati Rare Diseases, Inc.
- Dosage Form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- February 4, 2022
- Listing Expires
- December 31, 2027
- Application
- BLA761164
Need to source Enjaymo? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Sutimlimab | 50 mg/mL |
Drug Class
Classical Complement Pathway Inhibitor [EPC]Classical Complement Pathway Inhibitor [EPC]Classical Complement Pathway Inhibitors [MoA]
Packaging Options(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (55292-820-01) / 22 mL in 1 VIAL, SINGLE-DOSE